Rite Aid forecasts current-quarter profit above estimates
(Reuters) - Rite Aid Corp (RAD.N) forecast a current-quarter profit far above market estimates as the third-largest U.S. drugstore chain continued to sell more generic drugs, which carry higher profit margins.
The company expects first-quarter profit of between 8 to 9 cents per share, above the 4 cents analysts estimated, according to Thomson Reuters I/B/E/S.
Rite Aid, which trails Walgreen Co (WAG.N) and CVS Caremark Corp (CVS.N) in size, has been remodeling stores and emphasizing its loyalty program, while continuing to close some stores.
However, the company said fewer generic drug introductions in the back half of the fiscal year will hurt its margins.
For the full-year, the company forecast adjusted net income of between 4 to 19 cents per share. Analysts on average expect a profit of 14 cents per share.
Shares of Rite Aid were up about 3 percent at $2.98 in early morning trade on the New York Stock Exchange on Friday.
(Reporting by Aditi Shrivastava in Bangalore; Editing by Sreejiraj Eluvangal)
- California passes 'yes-means-yes' campus sexual assault bill
- IBM launches Watson system for research, hopes for breakthroughs
- Separatists say will allow 'trapped' Ukrainian forces to withdraw |
- In town halls, U.S. lawmakers hear voter anger over illegal migrants |
- U.N. says 43 Golan peacekeepers seized by Syria militants, 81 trapped